2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Chickenpox: new trials by email Literature Review of Chickenpox trials Research Report on Chickenpox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection, Candidate 1: PF-07915234: VZV modRNA Suspension for Injection, Candidate 2: PF-07921188: VZV modRNA Suspension for Injection - Shingles, Herpes Zoster Infection | Phase 1 / Phase 2 | Terminated | Pfizer | 484 | 2023-01-25 | 2026-05-04 |
| Immune Responses to Two Dose Varivax +/- MMR-II MMR-II, Pro-Quad, Varivax - Measles, Mumps | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 105 | 2005-10-01 | 2010-08-27 |
Herpes Zoster (1) · Measles (1) · Mumps (1) · Rubella (1)
DNA Virus Infections (2) · Herpesviridae Infections (2) · Infections (2) · Varicella Zoster Virus Infection (2) · Virus Diseases (2) · Mononegavirales Infections (1) · Morbillivirus Infections (1) · Mouth Diseases (1) · Paramyxoviridae Infections (1) · Parotid Diseases (1) · Parotitis (1) · RNA Virus Infections (1) · Rubivirus Infections (1) · Rubulavirus Infections (1) · Salivary Gland Diseases (1)
Chickenpox Vaccine (1) · Injections (1) · Suspensions (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pfizer (1)
United States (2)